PharmaMedic Announces Expanded Medical Affairs Solutions to Boost Branded Sales from Existing Generic Portfolios
PharmaMedic helps generic manufacturers navigate a growing but challenging market. Click to learn more
Unlocking the Power of UK Health Data to Transform Lives
An independent review by Professor Cathie Sudlow, Uniting the UK’s Health Data: A Huge Opportunity for Society, highlights the urgent need to tackle inefficiencies in the UK’s health data systems. Published on 8 November 2024, the review outlines how outdated processes are preventing the safe and secure use of health data to improve care, drive research, and benefit society.
5 Trends Shaping Medical Affairs in 2025 — Are You Ready?
As 2024 draws to a close, the question on everyone’s mind is — What’s next for medical affairs in 2025? With the healthcare landscape changing at an unprecedented pace, staying ahead means understanding the trends that will define the year ahead. From digital transformation to patient-centric strategies, these shifts are already reshaping the way medical affairs teams operate. Here’s what you need to know to stay prepared and relevant.
How Digital Opinion Leaders Are Shaping the Future of Medical Affairs
Healthcare is changing, and so is the way people influence it. Authority no longer stays locked in conference rooms or academic journals. Today, Digital Opinion Leaders (DOLs) drive key conversations online. These healthcare professionals shape debates that matter — bringing together peers, patients, and stakeholders in the digital spaces where they spend the most time. If your Medical Affairs strategy hasn’t tapped into the power of these digital voices, you might miss big opportunities to adapt, connect, and improve.
How Omnichannel KOL Engagement Drives Successful Medical Interactions
The pharmaceutical landscape is moving fast, and the importance of omnichannel engagement is becoming clear. Especially when it comes to reaching healthcare professionals (HCPs), and more specifically, Key Opinion Leaders (KOLs). These experts are at the forefront of medical advancements and reaching them in the right way can make all the difference. With the right omnichannel approach, you can build deeper, more meaningful relationships that cater to their unique preferences—helping them make decisions more efficiently in this ever-changing, complex field.
How-to Drive Patient Impact — Five Strategic Priorities for Medical Affairs
In today’s rapidly evolving healthcare landscape, Medical Affairs (MA) teams have taken on a pivotal role. They are no longer viewed as just support teams but are now essential in improving patient care, expanding access to treatments, and shaping the future of medicine. As healthcare becomes more complex, Medical Affairs is increasingly focusing on putting patients’ needs at the heart of every decision. By concentrating on five key areas, Medical Affairs can improve patient outcomes and strengthen the reputation of pharmaceutical companies.
London Bioscience Innovation Centre (LBIC) five years on
We marked our 5-year anniversary as a client of the London Bioscience Innovation Centre (LBIC) recently and featured in its Winter newsletter alongside Prokarium, MicrosensDx and VirTus and others.
Client Q&A: Dr Kathrine Scott, Gedeon Richter
In our latest article, we explore how PMC supports Dr Kathrine Scott of Gedeon Richter with new product launches and day to day copy approval. Read on to learn how we are helping this small medical team make a real impact.
Client Q&A: Olivia Marsh, Glenmark Pharmaceuticals
In our latest article, we explore how PharmaMedic Consultancy (PMC®) supports Glenmark Pharmaceuticals with their day to day promotional activities. Read on to learn how our medical affairs consultant seamlessly fits into our client's team and ensures commercial compliance.
To succeed with a Marketing Authorisation extension or Variation, it is essential that Regulatory and Medical Affairs Teams work hand in hand
Collaboration is essential to drive innovation in pharma and bring new medicines to patients. In this article, we discuss how close cooperation between regulatory and medical affairs helps to streamline regulatory interactions.